CS
BIOL

Credit Suisse’s Biolase, Inc. BIOL Stock Holding History

Credit Suisse’s Portfolio BIOL Stock Details BIOL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-18
Closed -$29K – 4704
2021
Q3 		$29K Buy
+18
New +$29.4K ﹤0.01% 4358
2015
Q2 		– Sell
-1
Closed -$35K – 4668
2015
Q1 		$35K Sell
1
-3
-75% -$85K ﹤0.01% 4303
2014
Q4 		$146K Buy
+4
New +$125K ﹤0.01% 4362
2014
Q3 		– Sell
-4
Closed -$97K – 4693
2014
Q2 		$97K Buy
4
+2
+100% +$51.1K ﹤0.01% 4543
2014
Q1 		$73K Hold
2
– – ﹤0.01% 4550
2013
Q4 		$56K Sell
2
-1
-33% -$23.7K ﹤0.01% 4522
2013
Q3 		$72K Buy
+3
New +$96.6K ﹤0.01% 4135

Other funds holding BIOL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Credit Suisse's BIOL Position: Q4 2021 in Review

Credit Suisse sold out of Biolase, Inc. (BIOL) in Q4 2021, closing a stake of 18 shares — an estimated $29K sold.

Credit Suisse first reported a position in BIOL in Q3 2013 and held it in 7 quarters. The position peaked at $146K in Q4 2014. 38 funds tracked by Wall St. Rank hold BIOL as of Q4 2021.

  • Credit Suisse reported no remaining Biolase, Inc. position as of Q4 2021 after selling out during the quarter.
  • Credit Suisse sold 18 Biolase, Inc. shares in Q4 2021, an estimated $29K.
  • Credit Suisse first reported a position in Biolase, Inc. in Q3 2013 and held it in 7 quarters.
  • Credit Suisse's Biolase, Inc. position peaked at $146K in Q4 2014.
  • 38 funds tracked by Wall St. Rank held Biolase, Inc. as of Q4 2021.

Based on Credit Suisse's 13F filing for Q4 2021, filed 14 Feb 2022.